Dr. Reddy’s Rituximab Biosimilar Receives US FDA Approval, Strengthening Global Biologics Portfolio
Dr. Reddy's Laboratories has achieved another major milestone with the US FDA…
IPA Seeks to Regularise Legacy Drugs in India: What It Means for the Pharmaceutical Industry
The IPA Legacy Drugs Regularisation India initiative has emerged as an important…
Amgen Data Breach 2026: Patient Health Information Potentially Exposed in Cybersecurity Incident
Global biotechnology company Amgen has disclosed a significant cybersecurity incident that may…
AI in Pharma R&D: Advanced Digital Technologies Are Rewiring Drug Discovery and Development
The adoption of AI in Pharma R&D is accelerating as pharmaceutical companies…
AbbVie Q2 2026 Results: Skyrizi and Rinvoq Drive Double-Digit Revenue Growth Despite Humira Decline
The AbbVie Q2 2026 Results demonstrate the company's successful transition beyond its…
Sun Pharma Q1 FY27 Results: Revenue Grows 10.1%, India Business Up 16%
Sun Pharma Q1 FY27 Results reported a strong start to FY2027, with…
FDA Flags Viatris’ TOBI Podhaler Promotional Video for Misleading Usage Claims
The FDA Viatris TOBI Podhaler Untitled Letter has drawn attention to the…
Obesity Drug Market Outlook 2026: Novo Nordisk, Eli Lilly & GLP-1 Competition Reshape Future Growth
The Obesity Drug Market Outlook 2026 highlights a major shift in the…
PCI Announces Carryover Provision for Existing B.Pharm Students: What You Need to Know
The Pharmacy Council of India (PCI) has issued an important notification regarding…
BDR Pharmaceuticals to Acquire Acme Formulation: $250 Million CDMO Deal Explained
Quick Summary BDR Pharmaceuticals is reportedly in talks to acquire Acme Formulation…
India to Launch Integrated Drug Regulatory Portal in 18 Months to Transform Pharma Regulatory Compliance
India is preparing to launch a new Integrated Drug Regulatory Portal that…
FDA Approves Tylenol with Naproxen: First 12-Hour OTC Pain Relief Tablet Combining Acetaminophen and Naproxen
Quick Summary FDA Approves Tylenol with Naproxen, the first over-the-counter (OTC) fixed-dose…
Eris Life Sciences Plans Insulin Aspart Launch; Expects Stronger Semaglutide Growth After Weight-Loss Approval
The Eris Life Sciences Insulin Aspart Launch marks an important step in…
Sandoz Owozy® (Semaglutide) Receives ANVISA Approval in Brazil: What It Means for Diabetes Care
Sandoz has achieved a significant regulatory milestone with the Sandoz Owozy Semaglutide…
US FDA Warns Almon Healthcare Over Serious CGMP Violations: Inspection Findings, Regulatory Concerns & Industry Impact
US FDA Warns Almon Healthcare Over Serious CGMP Violations The US FDA…
